Najat Khan - Apr 16, 2024 Form 3 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/Jonathan Golightly, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Apr 16, 2024
Transactions value $
$0
Form type
3
Date filed
4/25/2024, 05:08 PM
Next filing
Aug 5, 2024

No securities are beneficially owned.